|
NCRNA00171 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.764200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.258200E-02 |
| Normal-vs-Stage2 |
5.216300E-02 |
| Normal-vs-Stage3 |
6.302200E-01 |
| Normal-vs-Stage4 |
3.779200E-01 |
| Stage1-vs-Stage2 |
2.891600E-01 |
| Stage1-vs-Stage3 |
2.833000E-01 |
| Stage1-vs-Stage4 |
7.832000E-01 |
| Stage2-vs-Stage3 |
1.257200E-01 |
| Stage2-vs-Stage4 |
7.289600E-01 |
| Stage3-vs-Stage4 |
4.342000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.242600E-03 |
| Normal-vs-AfricanAmerican |
9.760400E-02 |
| Normal-vs-Asian |
9.826600E-01 |
| Caucasian-vs-AfricanAmerican |
6.375800E-01 |
| Caucasian-vs-Asian |
3.669400E-01 |
| AfricanAmerican-vs-Asian |
5.115600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.669560E-02 |
| Normal-vs-Female |
1.660060E-02 |
| Male-vs-Female |
4.092400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.120600E-01 |
| Normal-vs-Extreme_Weight |
1.342240E-01 |
| Normal-vs-Obese |
2.803600E-02 |
| Normal-vs-Extreme_Obese |
1.954620E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.072200E-01 |
| Normal_Weight-vs-Obese |
2.908600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.815400E-01 |
| Extreme_Weight-vs-Obese |
3.680800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.979600E-01 |
| Obese-vs-Extreme_Obese |
8.309200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.013600E-02 |
| Normal-vs-Age(41-60Yrs) |
4.981500E-03 |
| Normal-vs-Age(61-80Yrs) |
4.374000E-02 |
| Normal-vs-Age(81-100Yrs) |
9.262000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.463000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.160550E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.252000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.261800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.284790E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.882200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.615000E-04 |
| Normal-VS-Type2 PRCC |
8.722000E-01 |
| Normal-VS-KIRP CIMP |
4.503700E-02 |
| Normal-VS-Unclassified PRCC |
3.875800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.373800E-04 |
| Type1 PRCC-VS-KIRP CIMP |
8.987900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.719600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.131900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.243400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.522000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.531200E-01 |
| Normal-vs-N1 |
6.121900E-02 |
| Normal-vs-N2 |
2.042200E-01 |
| N0-vs-N1 |
5.280000E-02 |
| N0-vs-N2 |
2.402800E-01 |
| N1-vs-N2 |
1.314000E-01 |
|
|
